Organto Foods (OGO) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jun, 2026Executive summary
Achieved record third quarter sales of $15.1 million, up 189% year-over-year, and record gross profit of $1.2 million, up 101% year-over-year.
Nine-month sales reached $45.9 million, a 222% increase year-over-year, already surpassing total fiscal 2024 sales by 122%.
Balance sheet significantly strengthened through improved operations, debt restructuring, and financing activities.
Financial highlights
Third quarter gross profit was $1.2 million (8.2% of sales); adjusted gross profit was $0.7 million (4.5% of sales) after currency hedging.
Cash operating expenses for Q3 were $1.3 million (8.7% of sales), down from 18.2% of sales in the prior year.
EBITDA for Q3 was $(0.7) million, reflecting improved operations but offset by derivative losses.
Net loss for Q3 was $2.0 million, including $1.7 million in non-recurring debt settlement losses; adjusted net income was $0.2 million.
Nine-month gross profit was $3.6 million (7.7% of sales); adjusted gross profit was $2.5 million (5.5% of sales) after currency hedging.
Nine-month net loss was $9.6 million, including $5.5 million in non-recurring debt settlement losses.
Outlook and guidance
Management expresses optimism for sustained growth, stability, and a clear path to profitability, citing momentum from restructuring and business realignment.
Latest events from Organto Foods
- Record sales and margin growth in Q1 2026 highlight scalable, efficient organic food operations.OGO
Corporate presentation8 Jun 2026 - Record sales and gross profit in 2023, but net loss widened amid restructuring and higher charges.OGO
Q4 20238 Jun 2026 - Q1 2024 saw improved net loss and cost cuts amid restructuring and 11% lower sales.OGO
Q1 20248 Jun 2026 - Q2 2024 delivered higher sales, net income, and lower overhead following restructuring and asset sales.OGO
Q2 20248 Jun 2026 - Q3 2024 delivered 47% sales growth and a sharply reduced net loss after restructuring.OGO
Q3 20248 Jun 2026 - Record Q4 sales and margin growth highlight strong momentum after restructuring.OGO
Q4 20248 Jun 2026 - Record sales, first positive EBITDA, and improved margins signal strong turnaround momentum.OGO
Q1 20258 Jun 2026 - Record sales and margin gains offset by non-recurring restructuring and debt settlement costs.OGO
Q2 20258 Jun 2026 - Record sales and EBITDA, strong balance sheet, and annualized sales surpass EUR 100 million.OGO
Q1 202628 May 2026